Study Procedures | Screening | Baseline evaluation | Post-intervention evaluation | Six-month evaluation |
---|---|---|---|---|
Timepoint | -T1 | T0 | T1 | T2 |
Informed consent | + | Â | Â | Â |
Inclusion/exclusion criteria | + | Â | Â | Â |
Demographics | Â | + | Â | Â |
Randomization | Â | + | Â | Â |
Primary outcome measure | ||||
 Functional Ambulation Category [30] |  | + | + | + |
Secondary outcome measures | ||||
 Impairment | ||||
  Fugl-Meyer Assessment (Lower extremity) [31] |  | + | + | + |
Functional | ||||
 5-Meter Walk test [32] |  |  | (+) | (+) |
 6-Minute Walk test [33] |  |  | (+) | (+) |
 Berg Balance Scale [34] |  | + | + | + |
 activPAL mean step count (in PT) |  |  | +a |  |
 Days to unassisted ambulation |  |  | +a |  |
 |  |  | + | |
Cognitive | ||||
 Montreal Cognitive Assessment [37] |  | + | + | + |
Quality of life | ||||
 Patient Health Questionnaire [38] |  | + | + | + |
 36-Item Short Form Survey [39] |  | + | + | + |
 Adverse events screen |  |  | +a | + |